Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$15,268,676
+$321,659 QoQ
Shares Held
60,120
-1.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
#877
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Essex Financial Services, Inc. holds $71,369,097 across 13 Drug Manufacturers - General names. JNJ ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,725 | $27,257,049 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
60,120 | $15,268,676 | |
| 3 | ABBV |
AbbVie Inc.
|
35,746 | $8,995,123 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,212 | $5,552,742 | |
| 5 | PFE |
Pfizer Inc
|
185,560 | $4,468,284 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
51,332 | $2,957,749 | |
| 7 | AMGN |
Amgen Inc
|
6,773 | $2,452,638 | |
| 8 | NVS |
Novartis AG
|
8,976 | $1,406,718 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,268,676 | 60,120 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $14,947,017 | 61,148 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $12,779,369 | 61,751 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $10,987,803 | 59,259 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $8,925,335 | 58,431 | Shares | Defined | 2025-07-16 | |
| 2025-03-31 | $9,771,458 | 58,921 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $8,689,058 | 60,082 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $10,155,814 | 62,667 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $10,566,198 | 72,292 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $9,775,192 | 61,794 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $10,315,686 | 65,814 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $10,442,414 | 67,046 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $12,003,841 | 72,522 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $11,511,385 | 74,267 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $13,445,891 | 76,116 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $12,383,014 | 75,802 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $13,440,169 | 75,715 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $13,283,034 | 74,948 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $12,984,384 | 75,901 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $12,363,794 | 76,556 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $12,420,078 | 75,392 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $12,390,675 | 75,392 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $10,970,802 | 69,709 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $10,393,759 | 69,813 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $9,249,235 | 65,770 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $8,654,973 | 66,003 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||